國際簡稱:J SKIN CANCER 參考譯名:皮膚癌雜志
主要研究方向:DERMATOLOGY 非預警期刊 審稿周期: 21 Weeks
《皮膚癌雜志》(Journal Of Skin Cancer)是一本由Hindawi Limited出版的以DERMATOLOGY為研究特色的國際期刊,發表該領域相關的原創研究文章、評論文章和綜述文章,及時報道該領域相關理論、實踐和應用學科的最新發現,旨在促進該學科領域科學信息的快速交流。該期刊是一本開放期刊,近三年沒有被列入預警名單。
The Journal Of Skin Cancer is an academic platform dedicated to the field of skin cancer, providing an opportunity for dermatologists, oncologists, pathologists and researchers in related fields around the world to share and exchange the latest research results. The publication of the journal aims to promote the early detection, accurate diagnosis and effective treatment of skin cancer, and improve the survival rate and quality of life of patients.
The journal covers a wide range of topics including, but not limited to, the molecular mechanisms of skin cancer, epidemiological research, novel diagnostic techniques, innovative treatments, patient care and management strategies. By publishing high-quality research in these areas, journals not only promote a deeper understanding of the basic science of skin cancer, but also accelerate innovation and technological advances for clinical applications. The journal's peer review process guarantees the academic quality and scientific rigor of published articles, providing readers with reliable and authoritative research information. In this way, the journal not only provides the latest scientific basis for the research and treatment of skin cancer, but also provides a wealth of teaching materials for education and training in related fields.
| CiteScore | SJR | SNIP | CiteScore 指數 | ||||||||||||
| 2.3 | 0.35 | 0.558 |
|
名詞解釋:CiteScore 是衡量期刊所發表文獻的平均受引用次數,是在 Scopus 中衡量期刊影響力的另一個指標。當年CiteScore 的計算依據是期刊最近4年(含計算年度)的被引次數除以該期刊近四年發表的文獻數。例如,2022年的 CiteScore 計算方法為:2022年的 CiteScore =2019-2022年收到的對2019-2022年發表的文件的引用數量÷2019-2022年發布的文獻數量 注:文獻類型包括:文章、評論、會議論文、書籍章節和數據論文。
| 按JIF指標學科分區 | 收錄子集 | 分區 | 排名 | 百分位 |
| 學科:DERMATOLOGY | ESCI | Q3 | 70 / 94 |
26.1% |
| 按JCI指標學科分區 | 收錄子集 | 分區 | 排名 | 百分位 |
| 學科:DERMATOLOGY | ESCI | Q3 | 70 / 94 |
26.06% |